Figure 2.

Clinical nodal staging scores in the development cohort of 4770 patients who were treated with radical prostatectomy and bilateral pelvic lymphadenectomy for localised prostate cancer. The vertical axis is the probability of missing nodal disease (one minus sensitivity); the horizontal axis is the number of examined nodes. (A) Sensitivity of the pathological evaluation of nodal disease stratified by clinical tumour stage. (B) Sensitivity of the pathological evaluation of nodal disease stratified by biopsy Gleason score. (C) Sensitivity of the pathological evaluation of nodal disease stratified by preoperative prostate-specific antigen. (D) Sensitivity of the pathological evaluation of nodal disease stratified by preoperative risk grouping.